Bruker (BRKR) Tops Q2 EPS by 2c, Maintains Guidance

Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $396 million versus the consensus estimate of $392.06 million.

2015 Financial Outlook

Bruker’s 2015 financial outlook is unchanged. The Company expects to generate organic revenue growth of approximately one percent, and expects to increase its non-GAAP operating margin by more than 100 basis points compared to 2014. Non-GAAP EPS is expected to be flat in 2015, compared to 2014.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance